Effectiveness of and Implementation Strategies for 'Disfrutando'.
Part of paid clinical trials in Columbia, Missouri.
- Sponsor
- University of Missouri-Columbia
- Study ID
- NCT07023406
- Status
- Recruiting
Conditions
- Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Disfrutando — BEHAVIORALDisfrutando is a six-week, weekly intervention with a booster intervention at week 12. Intervention content includes glucose control with individual goals, glucose monitoring and glucometer practice, healthy eating demonstrations, benefits of physical activity, prevention and management of T2DM. The intervention has a strong focus on mitigating barriers and challenges to diabetes self-care management.
Study Details
Despite much research that has focused on enhancing type 2 diabetes mellitus (T2DM) health outcomes for high burden populations, more remains to be done. There is a need to develop practical approaches that not only equip people with knowledge about T2DM self-management, but also help them mitigate the adverse social determinants of health (SDOH) that are fueling the burgeoning numbers of people in the United States with T2DM and that are preventing them from practicing healthful behaviors. This study will examine an intervention named 'Disfrutando' that strives to help people prevent and manage T2DM.
Key Dates
- Start date
- Aug 1, 2025
- Status verified
- Jun 2025
- Primary completion
- May 15, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 31 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Intervention GroupBehavioral Intervention
- Experimental: Waitlist GroupThis arm will receive the intervention after the waitlist period
Primary Outcome Measure
Glucose (Blood Sugar) Control [ Time Frame: Hemoglobin A1C will be measured at baseline (pre-intervention), 12 weeks, and 6 months. ]
Central Contacts
- Maithe Enriquez, PhD18166863242
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Missouri | Columbia | Missouri | 65211 | - |
| Holy Cross Church | Kansas City | Missouri | 64123 | Wendy Mora |
Find similar trials in Columbia, MO
Related Studies
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)PHASE2 · Recruiting · University of Florida · Gainesville, Florida
- Human Immunodeficiency Virus (HIV) Food InsecuritiesRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- RCT Glargine vs NPH for Treatment of DM in PregnancyPHASE3 · Recruiting · Loyola University · Maywood, Illinois
- CGM for Management of Type 2 Diabetes in PregnancyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama